Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

938 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ibrutinib and Rituximab in Waldenström's Macroglobulinemia.
Dimopoulos MA, Salman Z, Buske C. Dimopoulos MA, et al. N Engl J Med. 2018 Nov 15;379(20):1975-1976. doi: 10.1056/NEJMc1809505. N Engl J Med. 2018. PMID: 30428288 No abstract available.
Fludarabine therapy in Waldenström's macroglobulinemia.
Dimopoulos MA, O'Brien S, Kantarjian H, Pierce S, Delasalle K, Barlogie B, Alexanian R, Keating MJ. Dimopoulos MA, et al. Am J Med. 1993 Jul;95(1):49-52. doi: 10.1016/0002-9343(93)90231-d. Am J Med. 1993. PMID: 8328496
Treatment of Waldenström's macroglobulinemia with rituximab.
Dimopoulos MA, Zervas C, Zomas A, Kiamouris C, Viniou NA, Grigoraki V, Karkantaris C, Mitsouli C, Gika D, Christakis J, Anagnostopoulos N. Dimopoulos MA, et al. J Clin Oncol. 2002 May 1;20(9):2327-33. doi: 10.1200/JCO.2002.09.039. J Clin Oncol. 2002. PMID: 11981004 Clinical Trial.
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
Dimopoulos MA, Zervas C, Zomas A, Hamilos G, Gika D, Efstathiou E, Panayiotidis P, Vervessou E, Anagnostopoulos N, Christakis J. Dimopoulos MA, et al. Clin Lymphoma. 2002 Dec;3(3):163-6. doi: 10.3816/clm.2002.n.022. Clin Lymphoma. 2002. PMID: 12521393 Clinical Trial.
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Dimopoulos MA, Hamilos G, Efstathiou E, Siapkaras I, Matsouka C, Gika D, Grigoraki V, Papadimitriou C, Mitsibounas D, Anagnostopoulos N. Dimopoulos MA, et al. Leuk Lymphoma. 2003 Jun;44(6):993-6. doi: 10.1080/1042819031000077025. Leuk Lymphoma. 2003. PMID: 12854900 Clinical Trial.
The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.
Dimopoulos M, Gika D, Zervas K, Kyrtsonis M, Symeonidis A, Anagnostopoulos A, Bourantas K, Matsouka C, Pangalis G. Dimopoulos M, et al. Leuk Lymphoma. 2004 Sep;45(9):1809-13. doi: 10.1080/10428190410001687512. Leuk Lymphoma. 2004. PMID: 15223640
Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression.
Dimopoulos MA, Alexanian R, Gika D, Anagnostopoulos A, Zervas C, Zomas A, Kyrtsonis MC, Anagnostopoulos N, Pangalis GA, Weber DM. Dimopoulos MA, et al. Leuk Lymphoma. 2004 Oct;45(10):2057-61. doi: 10.1080/10428190410001723287. Leuk Lymphoma. 2004. PMID: 15370250 Clinical Trial.
Adverse effects of thalidomide administration in patients with neoplastic diseases.
Dimopoulos MA, Eleutherakis-Papaiakovou V. Dimopoulos MA, et al. Am J Med. 2004 Oct 1;117(7):508-15. doi: 10.1016/j.amjmed.2004.03.040. Am J Med. 2004. PMID: 15464708 Review.
How we treat Waldenström's macroglobulinemia.
Dimopoulos MA, Merlini G, Leblond V, Anagnostopoulos A, Alexanian R. Dimopoulos MA, et al. Haematologica. 2005 Jan;90(1):117-25. Haematologica. 2005. PMID: 15642678 Review.
Diagnosis and management of Waldenstrom's macroglobulinemia.
Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Dimopoulos MA, et al. J Clin Oncol. 2005 Mar 1;23(7):1564-77. doi: 10.1200/JCO.2005.03.144. J Clin Oncol. 2005. PMID: 15735132 Review.
938 results
Jump to page
Feedback